-3x Short Japan (JPNS) Quote

https://x.com/WallStreetApes/status/1873050975390375937

Your going to need more news to get this to move any more thin has volume as dried up

That is correct... and makes my point. Those could just be "dropped" because they were never an operating business. They were nothing but a concept. On the other hand. Pretzel Haus was an operating business that left a trail of debt, judgments and fraud. That cannot just be dripped until is obligati

The MM's are only too happy to work with Institutions to do their bidding.   They will also go short themselves to fill the order. 

Gary 

KORE.........................nice move.....https://stockcharts.com/h-sc/ui?s=kore&p=W&b=5&g=0&id=p86431144783

You’ve been hyping this POS for 10 years while I’ve been gratified by good investment decisions.

Babble some more about irrelevant garbage.

Channel Of Destiny......or in other words ;


https://investorshub.advfn.com/uimage/uploads/2024/12/28/wmnvrxrp_121212_28_capt_11am_collage_chan_dest_resist.jpg

\

Hear! Hear!

In a prior analytical life we had a saying that our work products were 'good enough for who they were for', this usually applied when management provided fewer resources than we thought necessary to appropriately answer their questions. I often think these management teams are today drooling at the

Merck has nothing to do with NWBO. This company is all about the trainwreck P3 which they had zero confidence in submitting to the only market that matters.

Look at the volume leading up to 5-10. Be just under the 13D requirements @ the end of April. Start buying to have to file then dump not passing the 10 day threshold. Might not be exactly at 100 million but pretty damn close.

BIEL: #1 Breakout Board, 911 Market Maker final trade Friday, nearly 10,000 reads last hour, NEWS PENDING!

Yep, I agree, . . . and that's why I have all of them on - "IGNORE" !!!

~ Lol

~ $WDLF ~

It won't be the first time someone spams the board with the TRUTH.....

Right..........Right........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹

No. They didn't post a link (they posted the graphic) and if you are familiar with Stocktwits, you'll know it's now hopelessly buried.

I did, however, post this information and its source some days ago when it was fresh and I think everyone but you and perhaps frrol saw that.

BIEL: #1 Breakout Board, 911 Market Maker final trade Friday, nearly 10,000 reads last hour, NEWS PENDING!

What NWBO trial failed?
They had one for prostate cancer that they never followed through on by know of none that failed.

[pre]

Financials lists the Income Statement, Balance Sheet and Cash Flow statements (annual and quaterly) reported.
Name BRL in Million except per share data

TTM
2023
2022
2021
2020
2019
2018
2017
2016

The pumpers are already positioning the company for the following (post UK approval):

1) Revenue recognition from UK will be swift, particularly with support of $50M in additional financing available.

2) New combo trial endpoints will allow quick results.

Has nothing to do with what I said. But you don’t understand how drugs are approved so keep blabbering.

So little in the market and available.  I usually have an open bid @0.025, I did not get any.  Usually on drinks and drabs of small amounts from old shareholders cleaning out for tax reasons from now till end of year.  Maybe?

Garbage management end of story. 

When the MM's lose interest here, it's done.

They've been toying with the spread for months.

more than 20 weeks per my calculations . . . so does that even make sense.
Curve is a alleging this Big Money investor believed NWBO/DCVAX was going to be a Big success with the announcement and accumulated 100 million shares which was about $75 million at the time). Was there news 20 weeks (

Fam they already said commercialization starts in 2025. Their partner Aran R&D has also stated such (check their website and LinkedIn) Aran R&D doesn't play around they are heavy hitters in the medical tech space (just look at their portfolio and exits). Turn your phone off for a few months then che